Target intelligence / Profile preview

Cancer-Associated Fibroblast Phenotype Modulation (CAF Phenotype Modulation)

Target: CAF Phenotype Modulation
Molecular classification: Cellular Process, Microenvironment Modulation

Overview

Cancer-associated fibroblasts (CAFs) are a major component of the tumor microenvironment (TME). The modulation of CAF phenotype refers to the processes by which these cells are activated, maintained, or reprogrammed within tumors, influencing cancer progression, metastasis, immune evasion, and therapy resistance. These processes can be targeted therapeutically to revert or suppress pro-tumorigenic functions of CAFs.

Other names: CAF ActivationCAF ReprogrammingCAF DifferentiationTumor Microenvironment ModulationFibroblast Activation in Cancer

Mechanism of action

Inhibition of signaling pathways that promote CAF activation; disruption of exosome-mediated communication; modulation of microenvironmental acidity.

Biological functions

ECM remodelingCytokine secretionGrowth factor secretionAngiogenesis supportImmunosuppressionDrug resistanceTumor growth promotionMetastasis promotion

Disease associations

CancerTumor microenvironmentMetastasisDrug resistance

Safety considerations

Potential for off-target effects on normal fibroblastsRisk of disrupting normal tissue homeostasisPotential for paradoxical effects on tumor growth or metastasisDevelopment of resistance to targeted therapies

Interacting drugs

TGFβ inhibitors

9 more in the full profile.

Biomarkers

CAF markers (e.g., αSMA, FAP)ECM components (e.g., collagen, fibronectin)Cytokine levels (e.g., VEGF, PDGF, FGF)Signaling pathway activity (e.g., p-STAT3, p-AKT)

Beyond the preview

Go deeper on Cancer-Associated Fibroblast Phenotype Modulation (CAF Phenotype Modulation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer-Associated Fibroblast Phenotype Modulation (CAF Phenotype Modulation).

Explore the full profile